A
C
T
G

The world is
talking about
RNA therapy.

Scroll To Learn More
Press Releases
5 - 25 - 2021
Shape Therapeutics to Present the Discovery of Muscle-Specific AAVs at the Jefferies 2021 Virtual Healthcare Conference
5 - 04 - 2021
Shape Therapeutics to Present at ASGCT Annual Meeting
4 - 20 - 2021
Shape Therapeutics Welcomes Patrick Bigot as its Chief Business Officer
1 - 11 - 2021
Shape Therapeutics to Highlight RNA Editing Technology Platform Advancements in Parkinson’s Disease and the Identification of Novel CNS-targeting AAV Variants at the J.P. Morgan 39th Annual Healthcare Conference
12 - 08 - 2020
Shape Therapeutics Announces Appointment of Gary Fortin as Chief Operating Officer
12 - 03 - 2020
Shape Therapeutics Unveils AAVid™ Capsid Discovery Platform and Identification of Novel Tissue-Specific AAV Variants, Solving a Fundamental Delivery Challenge in Gene Therapy
11 - 19 - 2020
ShapeTx to present at the 2nd RNA Editing Summit, Boston MA
10 - 01 - 2020
ShapeTX to present groundbreaking advances in ADAR-Mediated RNA editing in Parkinson’s Disease at the Jefferies Gene Therapy and Editing Summit
8 - 10 - 2020
ShapeTX to present at the BTIG Virtual Biotechnology Conference
7 - 07 - 2020
ShapeTX to present at the SVB Leerink Biopharma Private Company Connect
6 - 29 - 2020
ShapeTX to present at the Oppenheimer Private Life Sciences Company Call Series
6 - 02 - 2020
ShapeTX to present at the Jefferies Virtual Healthcare Conference
2 - 25 - 2020
ShapeTX to present at the 9th Annual SVB Leerink Global Healthcare Conference New York
11 - 19 - 2019
ShapeTX to present at the 1st RNA Editing Summit , Boston MA
11 - 05 - 2019
Shape Therapeutics raises $35.5M in Series A financing.
Swipe Left To Learn More
News
Developing A NextGen RNA Therapy for Rett Syndrom
Dec, 16th, 2020.
Read articleDeveloping A NextGen RNA Therapy for Rett Syndrom
ShapeTX Claims Breakthrough in Tissue-Specific Gene Therapies
Dec, 8th, 2020
Read article
8 Innovative Tech Companies to Watch for in 2021
Tech Report- Nov 30th 2020
Read article
Nature Biotechnology’s academic spinouts of 2019
Nature Biotechnology — Apr 23rd 2020
Learn More
7 Innovative Startups to Watch in 2020
Inc.com — Jan 6th 2020
Learn More
ShapeTx: Shaping up RNA editing
Biocentury — Nov 21st 2019
Learn More
As CRISPR horizons cloud, a startup focuses on the next big thing with powerhouse potential—the RNA editing platform
Endpoints News — Nov 5th 2019
Learn More
    Developing A NextGen RNA Therapy for Rett Syndrom
    Dec, 16th, 2020.
    Read articleDeveloping A NextGen RNA Therapy for Rett Syndrom
    ShapeTX Claims Breakthrough in Tissue-Specific Gene Therapies
    Dec, 8th, 2020
    Read article
    8 Innovative Tech Companies to Watch for in 2021
    Tech Report- Nov 30th 2020
    Read article
    Nature Biotechnology’s academic spinouts of 2019
    Nature Biotechnology — Apr 23rd 2020
    Learn More
    7 Innovative Startups to Watch in 2020
    Inc.com — Jan 6th 2020
    Learn More
    ShapeTx: Shaping up RNA editing
    Biocentury — Nov 21st 2019
    Learn More
    As CRISPR horizons cloud, a startup focuses on the next big thing with powerhouse potential—the RNA editing platform
    Endpoints News — Nov 5th 2019
    Learn More
Swipe Left To Learn More
Publications
5 - 14 - 2021
AAVid: A Platform for Intelligently Engineering AAV Capsids from Massively Diverse Libraries
5 - 14 - 2021
Deep Screening of Guide RNAs Enables Therapeutic RNA Editing with Endogenous ADAR
1 - 13 - 2021
Robust RNA editing via recruitment of endogenous ADARs using circular guide RNAs
9 - 09 - 2020
Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA base-editing activity, functionality and specificity
8 - 27 - 2019
Immune-orthogonal Orthologues of AAV Capsids and of Cas9 Circumvent in the Immune Response to the Administration of Gene Therapy
4 - 03 - 2019
RNA-Guided Adenosine Deaminases: Advances and Challenges for Therapeutic RNA Editing
2 - 08 - 2019
In vivo RNA Editing of Point Mutations via RNA-guided Adenosine Deaminases
2 - 26 - 2018
Oligonucleotide Conjugated Multi-Functional Adeno-Associated Viruses
10 - 28 - 2017
In Vivo RNA Targeting of Point Mutations via Suppressor tRNAs and Adenosine Deaminases
Swipe Left To Learn More

Media Kit

Logos

Images

water2

Next:

Therapeutics Platform